iNOS and COX‐2 in Ischemic Stroke

[1]  Hong Wang,et al.  Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. , 2005, Cerebral cortex.

[2]  M. Ross,et al.  Obligatory Role of Inducible Nitric Oxide Synthase in Ischemic Preconditioning , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  C. Iadecola,et al.  Nitric Oxide Inhibits Caspase Activation and Apoptotic Morphology but Does Not Rescue Neuronal Death , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  C. Iadecola,et al.  The Janus Face of Cyclooxygenase-2 in Ischemic Stroke: Shifting Toward Downstream Targets , 2005, Stroke.

[5]  C. Iadecola,et al.  Interaction Between Inducible Nitric Oxide Synthase and Poly(ADP-ribose) Polymerase in Focal Ischemic Brain Injury , 2004, Stroke.

[6]  G. Brown,et al.  Nitric oxide, hypoxia and brain inflammation. , 2004, Biochemical Society transactions.

[7]  T. Takadera,et al.  Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons , 2004, Neurochemistry International.

[8]  M. Ross,et al.  Prostanoids, not reactive oxygen species, mediate COX‐2–dependent neurotoxicity , 2004, Annals of neurology.

[9]  M. Moskowitz,et al.  Targeting eNOS for stroke protection , 2004, Trends in Neurosciences.

[10]  D. Wink,et al.  Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  Pasko Rakic,et al.  JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. McCullough,et al.  Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia , 2004, The Journal of Neuroscience.

[13]  M. Hori,et al.  Amelioration of Hippocampal Neuronal Damage after Transient Forebrain Ischemia in Cyclooxygenase-2—Deficient Mice* , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  K. Takeuchi,et al.  Prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats through EP1 receptors. , 2003, Life sciences.

[15]  K. Nakao,et al.  Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats , 2003, Hypertension.

[16]  A. Mulichak,et al.  The structure of mammalian cyclooxygenases. , 2003, Annual review of biophysics and biomolecular structure.

[17]  M. Tymianski,et al.  Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. , 2003, Cell calcium.

[18]  N. Bazan,et al.  Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. , 2003, Investigative ophthalmology & visual science.

[19]  T. Sugawara,et al.  Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. , 2003, Antioxidants & redox signaling.

[20]  C. Saper,et al.  Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors. , 2003, The Journal of physiology.

[21]  R. Traystman,et al.  Neuronal overexpression of cyclooxygenase‐2 increases cerebral infarction , 2003, Annals of neurology.

[22]  Paul L Huang,et al.  Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse Kidney* , 2003, Journal of Biological Chemistry.

[23]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[24]  N. Tamaki,et al.  Post-ischemic cyclooxygenase-2 expression is regulated by the extent of cerebral blood flow reduction in non-human primates , 2003, Neuroscience Letters.

[25]  C. Iadecola,et al.  Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia , 2003, Brain Research.

[26]  N. V. Chandrasekharan,et al.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Szabó,et al.  The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.

[28]  Y. Sugimoto,et al.  Prostanoid receptor subtypes. , 2002, Prostaglandins & other lipid mediators.

[29]  I. Song,et al.  The enzymology of prostaglandin endoperoxide H synthases-1 and -2. , 2002, Prostaglandins & other lipid mediators.

[30]  S. Narumiya,et al.  Function of prostanoid receptors: studies on knockout mice. , 2002, Prostaglandins & other lipid mediators.

[31]  N. Bazan,et al.  Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. , 2002, Journal of neurophysiology.

[32]  R. Bolli,et al.  Role of Nitric Oxide in Myocardial Preconditioning , 2002, Annals of the New York Academy of Sciences.

[33]  G. Pasinetti,et al.  Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. , 2002, The Journal of pharmacology and experimental therapeutics.

[34]  N. Noshita,et al.  Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals , 2002, Stroke.

[35]  P. Cohen,et al.  The Induction of Cyclooxygenase-2 mRNA in Macrophages Is Biphasic and Requires both CCAAT Enhancer-binding protein β (C/EBPβ) and C/EBPδ Transcription Factors* , 2001, The Journal of Biological Chemistry.

[36]  M. Ross,et al.  Cyclooxygenase-2 Inhibitor NS-398 Protects Neuronal Cultures From Lipopolysaccharide-Induced Neurotoxicity , 2001, Stroke.

[37]  B. Gaston,et al.  S-Nitrosylation of mitochondrial caspases , 2001, The Journal of cell biology.

[38]  Guy C. Brown,et al.  Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.

[39]  I. Fridovich,et al.  Neuroprotection from Delayed Postischemic Administration of a Metalloporphyrin Catalytic Antioxidant , 2001, The Journal of Neuroscience.

[40]  R. Breyer.  Prostaglandin EP(1) receptor subtype selectivity takes shape. , 2001, Molecular pharmacology.

[41]  L. Favalli,et al.  The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat , 2001, Neuroscience Letters.

[42]  P. Lapchak,et al.  Neuroprotection by the Selective Cyclooxygenase-2 Inhibitor SC-236 Results in Improvements in Behavioral Deficits Induced by Reversible Spinal Cord Ischemia , 2001, Stroke.

[43]  M. Ross,et al.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Plotkine,et al.  Antisense Oligodeoxynucleotide to Inducible Nitric Oxide Synthase Protects against Transient Focal Cerebral Ischemia—Induced Brain Injury , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  P. Chan.  Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  D. Choi,et al.  Brain tissue responses to ischemia. , 2000, The Journal of clinical investigation.

[47]  M. Ross,et al.  Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase , 2000, Brain Research.

[48]  Gary Brewer,et al.  Regulation of Cyclooxygenase 2 mRNA Stability by the Mitogen-Activated Protein Kinase p38 Signaling Cascade , 2000, Molecular and Cellular Biology.

[49]  T. Uliasz,et al.  Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. , 2000, The Journal of pharmacology and experimental therapeutics.

[50]  S. Ghosh,et al.  Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages* , 2000, The Journal of Biological Chemistry.

[51]  M. Ross,et al.  Cyclooxygenase-2 Contributes to Functional Hyperemia in Whisker-Barrel Cortex , 2000, The Journal of Neuroscience.

[52]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[53]  G. Pasinetti,et al.  Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. , 1999, The American journal of pathology.

[54]  M. Ross,et al.  Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia , 1999, Acta Neuropathologica.

[55]  G. Böhme,et al.  Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury , 1999, British journal of pharmacology.

[56]  M. Ross,et al.  Inducible nitric oxide synthase expression in human cerebral infarcts , 1999, Acta Neuropathologica.

[57]  S. Love.  Oxidative Stress in Brain Ischemia , 1999, Brain pathology.

[58]  Simon C Watkins,et al.  Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[59]  C. Iadecola,et al.  Delayed Treatment with Aminoguanidine Decreases Focal Cerebral Ischemic Damage and Enhances Neurologic Recovery in Rats , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  Atsushi Ichikawa,et al.  Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 , 1998, Nature.

[61]  P. Isakson,et al.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Paetau,et al.  Cyclooxygenase‐2 is induced globally in infarcted human brain , 1998, Annals of neurology.

[63]  J. Thornhill,et al.  Intracerebroventricular prostaglandin administration increases the neural damage evoked by global hemispheric hypoxic ischemia , 1998, Brain Research.

[64]  Ulrich Dirnagl,et al.  Increased Formation of Reactive Oxygen Species after Permanent and Reversible Middle Cerebral Artery Occlusion in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  Tullio Pozzan,et al.  Prostaglandins stimulate calcium-dependent glutamate release in astrocytes , 1998, Nature.

[66]  Makoto Kawase,et al.  Mitochondrial Susceptibility to Oxidative Stress Exacerbates Cerebral Infarction That Follows Permanent Focal Cerebral Ischemia in Mutant Mice with Manganese Superoxide Dismutase Deficiency , 1998, The Journal of Neuroscience.

[67]  J. Licinio,et al.  Pathways and mechanisms for cytokine signaling of the central nervous system. , 1997, The Journal of clinical investigation.

[68]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[69]  Fangyi Zhang,et al.  Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.

[70]  J Zhang,et al.  Neuroprotective Effects of Inhibiting Poly(ADP-Ribose) Synthetase on Focal Cerebral Ischemia in Rats , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  M. Plotkine,et al.  Calcium‐independent NO‐synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice , 1997, British journal of pharmacology.

[72]  J. Stamler,et al.  Nitric Oxide Inhibits Fas-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[73]  T. Hökfelt,et al.  Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Epstein,et al.  Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.

[75]  T. Dawson,et al.  Nitric oxide synthase in models of focal ischemia. , 1997, Stroke.

[76]  M. Ross,et al.  Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage , 1997, The Journal of Neuroscience.

[77]  K. Seibert,et al.  Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.

[78]  C. Iadecola.  Bright and dark sides of nitric oxide in ischemic brain injury , 1997, Trends in Neurosciences.

[79]  M. Harrison,et al.  Cyclo-oxygenase-2 Messenger RNA Induction in Focal Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  M. Moskowitz,et al.  Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice are Attenuated by Nitro-L-Arginine , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[81]  M. Ross,et al.  Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. , 1996, Stroke.

[82]  P. Worley,et al.  COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[83]  V. Bindokas,et al.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[84]  C. Piantadosi,et al.  Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. , 1996, Stroke.

[85]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[86]  C. Nathan,et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.

[87]  D. Dewitt,et al.  Characterization of inducible cyclooxygenase in rat brain , 1995, The Journal of comparative neurology.

[88]  M. Ross,et al.  Inducible Nitric Oxide Synthase Gene Expression in Brain following Cerebral Ischemia , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[89]  M. Ross,et al.  Marked Induction of Calcium-Independent Nitric Oxide Synthase Activity after Focal Cerebral Ischemia , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[90]  C. Y. Chen,et al.  Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements , 1994, Molecular and cellular biology.

[91]  S. Narumiya,et al.  Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity , 1994, Brain Research.

[92]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[93]  S H Snyder,et al.  Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Y. Vodovotz,et al.  Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. , 1994, Journal of immunology.

[95]  C. Bonne,et al.  Protection by prostaglandins from glutamate toxicity in cortical neurons , 1994, Neurochemistry International.

[96]  F. Barone,et al.  Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study , 1993, Brain Research Bulletin.

[97]  G. FitzGerald,et al.  Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. , 1993, Molecular pharmacology.

[98]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[99]  R. Koehler,et al.  Oxygen radical mechanisms of brain injury following ischemia and reperfusion. , 1991, Journal of applied physiology.

[100]  J S Beckman,et al.  Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. , 1989, The American journal of physiology.

[101]  C. Nathan,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .

[102]  S. Moncada,et al.  Nitric oxide from inflammatory‐activated glia synergizes with hypoxia to induce neuronal death , 2005, Journal of neuroscience research.

[103]  N. Carlson.  Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase‐2 inhibitor APHS can be reversed by a prostanoid , 2003, Journal of neuroscience research.

[104]  M. O’Banion,et al.  Cyclooxygenase inhibition as a strategy to ameliorate brain injury. , 2002, Journal of neurotrauma.

[105]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[106]  M. Globus,et al.  Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[107]  J Garthwaite,et al.  Nitric oxide signaling in the central nervous system. , 1995, Annual review of physiology.

[108]  D. Choi,et al.  Detection of free radicals by microdialysis/spin trapping EPR following focal cerebral ischemia-reperfusion and a cautionary note on the stability of 5,5-dimethyl-1-pyrroline N-oxide (DMPO). , 1995, Free radical research.

[109]  C. Iadecola,et al.  Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. , 1995, The American journal of physiology.

[110]  S. Gross,et al.  Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.

[111]  O. Griffith,et al.  Nitric oxide synthases: properties and catalytic mechanism. , 1995, Annual review of physiology.

[112]  J. Beckman,et al.  Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. , 1995, Advances in pharmacology.